Screening of Cardiovascular Disease in Kazakhstan


  • Nurlan Jainakbayev
  • Almagul Mansharipova
  • Khadisha Kashikova
  • Aynur Eshmanova
  • Mussa Sakhipov



cardiological screening, CardioVisor, cardiovascular disease, ECG dispersive charting, risk factors for cardiovascular disorders, screening of rural population.


Background: Mass screening is an effective way to detect the risk of cardiological diseases early. Still, the main problems during mass
screening are the availability of screening methods and the efficiency of disease intelligence with a minimum expenditure of time.
Method of dispersive ECG charting proves to be the most effective from the point of sensitivity to metabolic changes in the Myocardium of
any origin (it provides a 95 % probability of detection of heart disease at an early stage) among non-invasive, easy-to-use methods of control
accessible for broad clinical practice. This method also provides unique information unobtainable by other methods in real-time regarding
transient functional disorders that are precursors of pathology.
Objective: The purpose of the study was to examine the dispersive ECG charting indexes related to various factors of risk of cardiovascular
disorders among the rural population of the southern region of Kazakhstan.
Method: We screened 500 rural residents of the Zhambyl Region of Kazakhstan to assess the state of the cardiovascular system. 12 standard
derivations and the dispersive ECG data were recorded using the Heart Screening System “CardioVisor 12C”. The “Statistika 7” program
processed statistical data.
Results: We observed the depreciation of the Myocardium’s compensatory mechanisms, violations of the Myocardium’s
electrophysiological properties, and autonomic dysfunction in heart rate with age.
Conclusion: The study revealed the highest percentage of changes in the cardiovascular system in virtually healthy people aged 40-49, which
might indicate the need for a dynamic monitoring of health and timely preventive measures.







How to Cite

Screening of Cardiovascular Disease in Kazakhstan. (2022). Journal of Pharmaceutical Negative Results, 13(3), 804-810.